Population-level utilisation of neoadjuvant radiotherapy for the treatment of rectal cancer.
Jessica GugusheffKahren M WhiteSuzanne FitzadamNicola CreightonAlexander EngelMark LeeStephen R ThompsonLorraine ChantrillJane YoungDavid CurrowPublished in: Journal of surgical oncology (2022)
The use of neoadjuvant radiotherapy for rectal cancer is highly variable, with differences only partially explained by assessable patient-or hospital-level factors. Understanding neoadjuvant radiotherapy utilisation patterns may assist in identifying barriers and opportunities to improve adherence to clinical guidelines.